Patent ID: 8846110
Filing Date: 2014-09-30
Classification: A61K,A61P,C08F

Abstract:
1. A therapeutic composition comprising a first polymer carrier; and a first anticancer agent attached to the first polymer carrier, optionally through a linker, wherein the first polymer carrier comprises a) a first monomer selected from the group consisting of N-(2-carboxypropyl) methacrylamide (2-CPMA) and N-(3-carboxypropyl)methacrylamide (3-CPMA) and b) optionally a second monomer; and wherein the first anticancer agent is attached to the first monomer or if the second monomer is present, the first anticancer agent is attached to the first monomer or the second monomer, wherein the first polymer carrier comprises one or more monomer units, and wherein each of the one or more monomer units is derivatized or underivatized.